Ultra-LEAF(TM) Purified anti-human CD3 317350 from BioLegend

Product Specs
ItemUltra-LEAF(TM) Purified anti-human CD3
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number317350
Quantity100 mg
ApplicationsFlow Cytometry (FC)
Conjugate/TagUnconjugated, Ultra Low Endotoxin Azide Free
Format0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative
ReactivityHuman
TargetCD3
IsotypeIgG2a, Kappa
CloneOKT3
HostMouse
Antibody TypePrimary
NCBI Full Gene NameCD3 epsilon subunit of T-cell receptor complex
NCBI Gene AliasesCD3epsilon, IMD18, T3E, TCRE
ClonalityMonoclonal

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

(2) HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responsesCell host & microbeMarch 10, 2021Clayton KL, Mylvaganam G, Villasmil-Ocando A, Stuart H, Maus MV, Rashidian M, Ploegh HL, Walker BD.

(3) Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cellsCellFebruary 18, 2021Glassman CR, Mathiharan YK, Jude KM, Su L, Panova O, Lupardus PJ, Spangler JB, Ely LK, Thomas C, Skiniotis G, et al.

(6) PPP2R2D suppresses IL-2 production and Treg functionJCI insightOctober 2, 2020Pan W, Sharabi A, Ferretti A, Zhang Y, Burbano C, Yoshida N, Tsokos MG, Tsokos GC.

(7) Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19CellOctober 1, 2020Sekine T, Perez-Potti A, Rivera-Ballesteros O, Strålin K, Gorin JB, Olsson A, Llewellyn-Lacey S, Kamal H, Bogdanovic G, Muschiol S, et al.

(8) FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cellsJournal for immunotherapy of cancerSeptember 1, 2020Campos Carrascosa L, van Beek AA, de Ruiter V, Doukas M, Wei J, Fisher TS, Ching K, Yang W, van Loon K, Boor PPC, et al.

(9) Oncolytic virus-derived type I interferon restricts CAR T cell therapyNature communicationsJune 24, 2020Evgin L, Huff AL, Wongthida P, Thompson J, Kottke T, Tonne J, Schuelke M, Ayasoufi K, Driscoll CB, Shim KG, et al.

(10) Anti-αLβ2 antibodies reveal novel endocytotic cross-modulatory functionalityBritish journal of pharmacologyJune 1, 2020Mancuso RV, Casper J, Schmidt AG, Krähenbühl S, Weitz-Schmidt G.

(11) Engineering and functionalization of large circular tandem repeat protein nanoparticlesNature structural & molecular biologyApril 1, 2020Correnti CE, Hallinan JP, Doyle LA, Ruff RO, Jaeger-Ruckstuhl CA, Xu Y, Shen BW, Qu A, Polkinghorn C, Friend DJ, et al.

(12) Multilevel defects in the hematopoietic niche in essential thrombocythemiaHaematologicaMarch 1, 2020Sun T, Ju M, Dai X, Dong H, Gu W, Gao Y, Fu R, Liu X, Huang Y, Liu W, et al.

(14) A Quantitative Multivariate Model of Human Dendritic Cell-T Helper Cell CommunicationCellOctober 3, 2019Grandclaudon M, Perrot-Dockès M, Trichot C, Karpf L, Abouzid O, Chauvin C, Sirven P, Abou-Jaoudé W, Berger F, Hupé P, et al.

(15) Evaluation of ultra-low input RNA sequencing for the study of human T cell transcriptomeScientific reportsJune 11, 2019Wang J, Rieder SA, Wu J, Hayes S, Halpin RA, de Los Reyes M, Shrestha Y, Kolbeck R, Raja R.

(16) Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12ImmunityDecember 18, 2018Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C, Engblom C, Pfirschke C, Siwicki M, Gungabeesoon J, et al.

(17) CRISPR/Cas9 genome editing in human hematopoietic stem cellsNature protocolsFebruary 1, 2018Bak RO, Dever DP, Porteus MH.

(18) Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustionThe Journal of experimental medicineNovember 14, 2016Hu Y, Kim JH, He K, Wan Q, Kim J, Flach M, Kirchhausen T, Vortkamp A, Winau F.

Ultra-LEAF(TM) Purified anti-human CD3 from BioLegend